Obesity

Explore the complexities of Obesity research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against Obesity with flcube.com.

FDA Approves Viatris's RYZUMVI for Presbyopia – Phentolamine Ophthalmic Solution 0.75% Adds Age‑Related Vision Indication to Existing Mydriasis Label
CompanyDrug

FDA Approves Viatris’s RYZUMVI for Presbyopia – Phentolamine Ophthalmic Solution 0.75% Adds Age‑Related Vision Indication to Existing Mydriasis Label

Viatris Inc. (NASDAQ: VTRS) announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults. RYZUMVI is already…

GSK Reports First Global Data for B7‑H3 ADC Risvutatug Rezetecan – 61% Confirmed ORR at 8 mg/kg in Relapsed ES‑SCLC Phase Ib

GSK Reports First Global Data for B7‑H3 ADC Risvutatug Rezetecan – 61% Confirmed ORR at 8 mg/kg in Relapsed ES‑SCLC Phase Ib

Qingfeng Pharmaceutical Signs Five‑Year Strategic Collaboration with China Association Against Epilepsy – Advancing Discipline Development, Talent Cultivation and Patient Assistance

Qingfeng Pharmaceutical Signs Five‑Year Strategic Collaboration with China Association Against Epilepsy – Advancing Discipline Development, Talent Cultivation and Patient Assistance

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Novo Nordisk's Semaglutide 7.2 mg Shows Superior Weight Loss in Phase III Study
CompanyDrug

Novo Nordisk’s Semaglutide 7.2 mg Shows Superior Weight Loss in Phase III Study

Hengrui and Kailera Announce Positive Phase II Results for HRS9531 in Weight Loss
CompanyDrug

Hengrui and Kailera Announce Positive Phase II Results for HRS9531 in Weight Loss

Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss
CompanyDrug

Tonghua Dongbao Begins Phase II Trial for GLP-1/GIP Agonist THDBH120 in Weight Loss

Novo Nordisk and Valo Health Expand Partnership to Develop Treatments for Obesity and Diabetes
CompanyDeals

Novo Nordisk and Valo Health Expand Partnership to Develop Treatments for Obesity and Diabetes

Verdiva Bio Launches with USD 411 Million Series A Financing for Biopharma Development
CompanyDeals

Verdiva Bio Launches with USD 411 Million Series A Financing for Biopharma Development

Eli Lilly & Co. Launches Mounjaro (Tirzepatide) in China for Diabetes and Weight Management
CompanyDrug

Eli Lilly & Co. Launches Mounjaro (Tirzepatide) in China for Diabetes and Weight Management

Corxel Pharmaceuticals Secures Global Rights to CX11, a Novel Oral GLP-1 RA, in Licensing Deal with Vincentage
CompanyDeals

Corxel Pharmaceuticals Secures Global Rights to CX11, a Novel Oral GLP-1 RA, in Licensing Deal with Vincentage

CSPC Pharmaceutical's SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial
CompanyDrug

CSPC Pharmaceutical’s SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial

Show More